Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following Its 20th Anniversary Robin Gauld Current Opinion 07 June 2014 Pages: 937 - 942
Decision-Analytic Models: Current Methodological Challenges J. Jaime CaroJörgen Möller Leading Article 02 July 2014 Pages: 943 - 950
Reconceptualising the External Validity of Discrete Choice Experiments Emily LancsarJoffre Swait Leading Article 12 June 2014 Pages: 951 - 965
Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models Paul TappendenJames B. Chilcott Practical Application 16 July 2014 Pages: 967 - 979
Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility Kevin MarshPeng XuIngolf Griebsch Review Article 13 July 2014 Pages: 981 - 993
Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes Zafar ZafariKristian ThorlundMohsen Sadatsafavi Original Research Article 12 June 2014 Pages: 995 - 1004
Cost–Utility Analysis of Chemotherapy Regimens in Elderly Patients with Stage III Colon Cancer David R. LairsonRohan C. ParikhXianglin L. Du Original Research Article 12 June 2014 Pages: 1005 - 1013
Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis An Tran-DuyAnnelies BoonenJohan L. Severens Original Research Article 28 June 2014 Pages: 1015 - 1028
Erratum to: Modelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to Consider Matt D. StevensonPeter L. Selby Erratum 30 August 2014 Pages: 1029 - 1029
Comment on “Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following its 20th Anniversary” Scott MetcalfeRachel GrocottDilky Rasiah Letter to the Editor Open access 11 September 2014 Pages: 1031 - 1033
